Reproductive Health 2024 Snua 020 (3)
Reproductive Health 2024 Snua 020 (3)
Reproductive Health 2024 Snua 020 (3)
2024/07/29
BY L.K.MOTSWASELE-SIKWANE
LEARNING OUTCOMES
• Client assessment and screening
• Follow-up visits
• Initiating contraceptive methods in non-menstrating women
• Management of side effects
• Emergency contraception
• Combination prevention
• Counselling in the context of contraceptive service provision
• processes for method provision
Introduction
History taking
• It is important to take a comprehensive personal medical history particularly before clients select
hormonal contraception, Cu IUD (copper intrauterine device), or sterilisation
HIV testing
• HIV counselling and testing, and discussions relating to risk and prevention, should be provided as a
routine part of the consultation. The frequency of an HIV test should be guided by possible
exposure to HIV, for both the client and their sexual partners. Clients who test HIV-positive should
be initiated onto antiretroviral treatment, as per national Test and Treat guidelines.
Sexually transmitted infection (STI) screening and management
• Should be done as an integrated part of contraception service provision, as per national DOH
guidelines.
Client assessment and screening CONT
Tuberculosis (TB)
• Due to the high incidence of HIV and TB co-infection, the consultation is an opportunity to screen,
provide information, treat, or refer, as per national DOH TB guidelines.
Blood pressure
• The measurement of blood pressure is essential for sterilisation. It is recommended that blood
pressure is measured before and during the use of hormonal contraception. However, where this is
not possible, hormonal methods should not be denied, providing there is no history of high blood
pressure. Where feasible, provision must be made to check blood pressure on a subsequent visit.
Pelvic examination
• This is only essential before fitting an intrauterine contraceptive device/system or before female
sterilisation, unless the need for a pelvic examination is indicated in the history taking. This needs to
be performed with sensitivity and with a focus on privacy and dignity.
Client assessment and screening CONT
Breast and cervical screening
• Where possible, the consultation should serve as an opportunity to educate clients about breast
self-examination and the purpose and value of cervical screening. Information should be provided
concerning the frequency of cervical screening, as per national guidelines. The actual screening,
where appropriate, can be done on the initiation of a contraceptive method or at a mutually agreed
appointment.
For HIV-positive women
• Provide a cervical screening on HIV diagnosis, and then every three years. If there is an abnormal
smear, manage according to national guidelines with annual checks recommended until resolved and
thereafter every three years.
For HIV-negative women
• Free cervical screenings from the age of thirty at ten-year intervals are recommended.
Screening for pregnancy
• Ensuring a client is not pregnant is important when screening for contraception. It is especially
recommended before starting hormonal contraceptives and before IUD insertion.
Follow-up visits
• Injection include:
changes to your periods, such as periods stopping, being irregular, or
lasting longer – the longer you use it the more likely it is that your
periods will stop completely.
Weight gain?
Pain, a small lump, or a scar where the injection is done
Noristerat/Nuristerate(Norethisterone
enantate)
• This lasts for 8 weeks, administered in your bum. Sometimes you may
have it in your upper arm.
• It’s usually used for short periods – for example, if your partner is
waiting for a vasectomy.
• A doctor or nurse does this type of injection.
When it starts to work
• Can have the injection at any time during your menstrual cycle, as
long as you’re not pregnant.
• If you have it during the first 5 days of your cycle, you’ll be
immediately protected against pregnancy.
• If you have it on any other day of your cycle, you should use
additional contraception such as condoms for 7 days.
Side effects of injectables
• Weight gain
• Description
• Weight gain is an increase in body weight. This can involve an
increase in muscle mass, fat deposits, excess fluids such as
water or other factors. Weight gain can be a symptom of a
serious medical condition
• Weight gain is a side effect of Depo-Provera. Also, women with
obesity are at higher risk of side effects of birth control,
Side effects of injectables
• Headaches
• Description
• Headache, also known as cephalalgia, is the symptom of pain
in the face, head, or neck. It can occur as a migraine, tension-
type headache, or cluster headache. There is an increased risk
of depression in those with severe headaches. Headaches can
occur as a result of many conditions
Su-ide effects of injectables
• Breast pain
• Description
• Breast pain is the symptom of discomfort in either one or both
breasts. Pain in both breasts is often described as breast
tenderness, is usually associated with the menstrual period and
is not serious.
• Spotting between periods
• Bleeding more days than usual. Spotting (light bleeding or
brown discharge between periods). Not getting your period at
all.
Side effects of injectables
• Periods may become irregular, heavier, lighter, longer, or
shorter. It may make acne worse.
Irregular bleeding
Irregular menstruation is a menstrual disorder whose
manifestations include irregular cycle lengths as well as
metrorrhagia.
The possible causes of irregular menstruation may vary.
The common factors are related to lifestyle, such as stress, body
weight, and smoking status
Types of implants:
• Emergency contraception (both emergency contraception pills and the Cu IUD) is effective within
120 hours (five days) after unprotected sex, the sooner it is used, the more effective.
Condoms
• effectiveness
• ensure clients know how to ameliorate symptoms and reassure them about the safety of their chosen method
• return to fertility, including when to return for additional supplies, next dosage, removal, and reinsertion